NP Life Sciences Health Industry Group Inc. financial data

Symbol
NPLS on OTC
Location
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2023 - Apr 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 267 % +266%
Return On Equity 148 %
Return On Assets -2.56 % +93.7%
Operating Margin -0.42 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43M shares 0%
Common Stock, Shares, Outstanding 43M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 4.3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 43M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 43M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 165K USD
General and Administrative Expense 165K USD +36.8%
Operating Income (Loss) -690 USD +96.3%
Nonoperating Income (Expense) -225 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.4K USD -588%
Net Income (Loss) Attributable to Parent -2.94K USD +84.4%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.6K USD -42.1%
Assets 76.9K USD -39.8%
Accounts Payable, Current 6.13K USD 0%
Accrued Liabilities, Current 25.1K USD +904%
Contract with Customer, Liability, Current 10K USD
Liabilities, Current 38.1K USD -64.9%
Liabilities 60.5K USD -44.2%
Retained Earnings (Accumulated Deficit) -348K USD -0.85%
Stockholders' Equity Attributable to Parent 31.7K USD +1068%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.4K USD -15.2%
Liabilities and Equity 76.9K USD -39.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.2K USD
Common Stock, Shares Authorized 320M shares 0%
Common Stock, Shares, Issued 43M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 18.2K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 30M shares 0%
Additional Paid in Capital 360K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%